Cresco Labs (CRLBF) Total Liabilities (2020 - 2026)

Cresco Labs' Total Liabilities history runs 7 years deep, the most recent figure standing at $954.6 million for Q1 2026.

• Quarterly Total Liabilities fell 3.43% year-over-year to $954.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $954.6 million (down 3.43% YoY) and the FY2025 annual result came in at $944.8 million, down 2.31% from the prior year.
• Total Liabilities was $954.6 million for Q1 2026 at Cresco Labs, up from $944.8 million in the prior quarter.
• Across five years, Total Liabilities topped out at $1.0 billion in Q1 2022 and bottomed at $917.4 million in Q2 2022.
• A 5-year average of $970.2 million and a median of $973.3 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 46.56% — and 2025, when it slipped 7.61%.
• Cresco Labs' Total Liabilities stood at $996.0 million in 2022, then declined by 6.59% to $930.4 million in 2023, then rose by 3.95% to $967.2 million in 2024, then decreased by 2.31% to $944.8 million in 2025, then gained by 1.04% to $954.6 million in 2026.
• Business Quant data shows CRLBF's Total Liabilities at $954.6 million in Q1 2026, $944.8 million in Q4 2025, and $940.2 million in Q3 2025.